PathHunter™ ß-arrestin Assays are revolutionary high-throughput screening assays for monitoring G-protein coupled receptor (GPCR) activation following ligand stimulation, without an imaging instrument, fluorescent protein tag, or radioactivity. Instead, the assays detect GPCR activation through ß-arrestin binding to the expressed GPCR of interest, measuring the interaction of the two proteins using enzyme fragment complementation (EFC)*. The EFC approach offers a range of benefits for screening, including signal amplification, high assay windows, robust performance, and a homogenous, single-addition assay format. The chemiluminescent signal generated can easily be read in 96-, 384- or 1536-well microplates with a standard luminometer, so library screening is simple, fast, and cost effecti...Read more
Receive your quote directly from DiscoveRx Corporation.
73 Targets in 101 cell pools are now available for demo or purchase!
Custom services also available
Features and Benefits
» Ideally suited for HTS with a single-addition, chemiluminescent detection protocol
» Directly screen broadest range of GPCRs— or deorphanize novel GPCRS
» Using a standard plate reader, the protocol is fast, simple, and reduces operating costs
» Use common cell types
PathHunter™ ß-arrestin Assay Principle
The assay detects binding of an agonist to a GPCR of interest by directly measuring ß-arrestin binding to the GPCR. Once bound, complementation occurs between the two ß-galactosidase components: the ProLink tag is fused to the C-terminus of the GPCR of interest; the Enzyme Acceptor (EA) is attached to ß-arrestin. These components interact only when in close proximity, forming active ß-gal enzyme that converts substrate to detectable signal.*
» ProLink™ Cloning Vector
» PathHunter™ ß-Arrestin CHO-K1, HEK 293, or U2OS Cell Lines
» PathHunter™ Detection Reagents
» Luminometer, Multimode Microplate Reader or CCD Camera
* Covered by issued and pending US and foreign patents.